Receptors and Cell Signaling Flashcards
1
Q
What are the types of signaling?
A
Endocrine, paracrine, autocrine, juxtacrine
2
Q
Endocrine signaling
A
- Long distance signaling
- Signal is made, goes to blood stream and targets distant cells
- FREELY DIFFUSIBLE signals that are LONG LASTING.
- Steroid hormones (epinephrine, leptin)
3
Q
Paracrine signaling
A
- Acts locally
- Affects cells that are nearby, do not freely diffuse
- Short lived
- Neurotransmitters
- Generally don’t want to go into bloodstream.
4
Q
Autocrine signaling
A
- Cells respond to signals they release or release to cells of the same type
- Cells secrete signal that feeds back and binds to a receptor on its own surface (has its own receptors)
- Ligands are not as long lasting
- Growth factors in cancer, chemokines,
- Important for immune response, homeostasis of tissues.
5
Q
Juxtacrine (Direct cell) signaling
A
- Molecule stays attached to signaling cell and binds to a receptor on adjacent target cell.
- PHYSICAL CONTACT between cells.
- Immune cells, Antigen presenting cells to T-cells
6
Q
Epinephrine on glucose metabolism
A
Encourages breakdown of glycogen by promoting glucose secretion
7
Q
Glucagon on glucose metabolism
A
Elevates blood glucose by promoting glycogen breakdown and gluconeogenesis
8
Q
Cortisol on glucose metabolism
A
If glycogen stores are depleted, stimulates gluconeogenesis by inducing transcription of enzymes in that pathway
9
Q
Insulin on glucose metabolism
A
Lowers blood glucose by promoting glycolysis and inhibiting gluconeogenesis
10
Q
Deficiency in insulin
A
Elevated blood glucose
11
Q
Types of signaling molecules (2)
A
lipophilic and hydrophilic
12
Q
Lipophilic signaling molecules
A
- Lipid soluble molecules that diffuse freely through lipid bilayer of PM
- HYDROPHOBIC, BIND INTRACELLULARLY
- Steroid hormones, retinoids, thyroid hormones
- Not water soluble, need carrier proteins
- Long half-life, administered daily
13
Q
Lipophilic receptors
A
- Binding leads to alterations in gene transcription
- Cytoplasmic receptors exist as inactive complex w/ HSP 90, when binding, complex disassociates from HSP
- Translocates to nucleus and binds to DNA sequence (HRE) in the promoter region
- Nuclear receptors – present in nucleus already bound to DNA
14
Q
Hydrophilic signaling molecules
A
- Receptor on surface, triggers activation of signaling events downstream from signal/molecule complex
- Small, derived from amino acids, lipid metabolism or small polypeptides (glucagon, insulin)
- Do not need carrier protein
- Most signaling molecules are hydrophilic and require cell-surface receptors
- Short half-life, administer when needed (epinephrine)
15
Q
Hydrophilic receptors
A
- Transmembrane proteins that undergo conformational change when binded to
- Cascade of signaling events
- GPCR - 7 alpha-helical transmembrane proteins
- Mediated by trimeric G-proteins, effector proteins and second messengers
- Receptor tyrosine kinases - single alpha helical transmembrane proteins
- Use enzymatic activity to initiate cascade of events mediated by monomeric G-proteins and kinases
16
Q
Lipophilic medication half-life
A
Hours to days, administered daily
17
Q
Hydrophilic medication
A
Like epinephrine, used to treat allergic reactions. Administer when needed.
18
Q
GPCR Structure
A
- Extracellular domain with binding site for specific signaling molecule
- Transmembrane domain of 7 a-helices
- Intracellular domain that interacts with trimeric G-protein (a, b, gamma)
19
Q
GPCR Sequence
A
- Signaling molecule binds in extracellular domain
- Conformational change in protein
- Intracellular domain activates trimeric G-protein (exchange GDP for GTP)
- G-protein is activated and interacts with membrane bound effector protein
- Signal termination (dissociation of signal from receptor, G-protein inactivation, reduction of second messenger, etc)
20
Q
Trimeric G-protein (a, b, gamma) states of activation
A
- Inactive G-protein: GDP-Ga (attached to beta/gamma)
- Active: GDP exchanged for GTP via GEF, Ga-GTP separates from beta, gamma
- Inactivation: intrinsic GTPase activity hydrolyzes GTP to GDP + Pi, accelerated by GAP
21
Q
GEF and GAP
A
- GEF is a protein that activates G-proteins by exchanging GDP for GTP
- GAP accelerates hydrolyzing activity of GTP to GDP + Pi
22
Q
Different GPCRs interact with different types of G-proteins
A
Gs, Gi, Gq, Gt
23
Q
Effector proteins
A
Membrane bound enzymes that catalyze reactions to produce second messengers (cAMP, cGMP, DAG, IP3)
24
Q
Common GPCR Signaling Pathways
A
- Signaling via Gs and Gi modulates adenylate cyclase and cAMP
- Signaling via Gt activates cGMP phosphodiesterase and lowers cGMP
- Signaling via Gq activates PLC and increases DAG, IP3, Ca2+
25
Same hormones can cause different responses in different cells
1. Epinephrine in smooth muscle relaxes
2. Epinephrine in cardiac muscle contracts
3. B-adrenergic receptor in both ex
26
B-agonists and their effects
1. B-agonist albuterol is a hydrophilic molecule that activates B2-adrenergic receptors
2. Administered to lungs to treat airway-constricting conditions
3. Pt's unresponsive to albuterol given epinephrine to relax bronchiol smooth muscles and stimulate heart contraction (tachycardia)
27
Nitric Oxide (NO) and smooth muscle relaxation
1. NO = endothelium-derived agent to relax smooth muscle.
2. Generated from arginine, promoted by calmodulin (Ca2+)
3. cGMP activates PKG --> smooth muscle relaxation and vasodilation
4. NO is anti-anginal
5. Pts taking nitroglycerin shouldn't take meds that inhibit cGMP phosphodiesterase --> extreme drop in BP
28
Antihistamines inhibit GPCR signaling
1. Symptoms of allergy caused by histamine (hydrophilic signaling molecule from histidine)
2. Histamine binds to 4 histamine GPCRs (H1-H4)
3. Antihistamines = lipophilic compounds that block binding of histamine to H1 GPCR to decrease allergic symptoms. Other antihistamines block H1 receptors and inhibit symptoms of motion sickness.
29
Epinephrine
B-adrenergic R --> Gs --> Relax SM, contract CM, breakdown glycogen in liver and muscle, glycolysis in muscle
30
Histamine
Histamine H2 R --> Gs --> bronchoconstriction and symptoms of allergies
31
Epinephrine/norepinephrine
A adrenergic R --> Gi --> SM constriction
32
Dopamine
dopamine D2 R --> increase HR
33
Acetylcholine
muscarinic acetylcholine M3 R --> Gq --> bronchoconstriction
34
Light
rhodopsin --> Gt --> vision
35
Receptor Tyrosine Kinases (RTK)
1. Extracellular signaling molecule-binding domain
2. Single alpha-helical transmembrane domain
3. Intracellular domain to process tyrosine K activity
36
Growth factors can bind to RTK and activate it
1. Ligand binds to RTK
2. Conformational change to cause receptor to dimerize
3. Phosphotyrosine residues recognize and bind by adaptor and docking proteins
4. Activate downstream signals that are RAS-dept or indept.
5. Phosphorylation of protein targets
6. Changes in transcription, protein activity
37
RAS-dependent vs. RAS-independent
RAS-dept: facilitated by members of MAPK
| RAS-indept: facilitated by other kinases
38
RTK Signal Termination
1. By degrading signaling molecules via proteases
2. Ligand-induced endocytosis of receptors + lysosomal degradation
3. Accelerated RAS inactivation
4. Dephosphorylation of target proteins by phosphoprotein phosphatase
39
RTK has long term AND short term effects
Long term: Gene transcription
| Short term: Change in protein activity already present in cell
40
Monomeric G-proteins
1. RAS, possess GTPase activity
2. Inactive when bound to GDP, active when bound to GTP
3. RAS cycles b/w inactive and active states with GEF and GAP
41
Insulin Signaling
1. Insulin binds to RTK to regulate glycogen and TAG metabolism
42
RAS dependent insulin signaling
1. Insulin binds to RTK
2. Autophosphorylation of receptor tyrosines
3. P-tyrosines recognize and bound by insulin R substrate (IRS1)
4. IRS1 gets phosphorylated on its tyrosine residues by insulin receptor
5. P-IRS1 recognized and bound by GRB-2
6. Activate RAS and MAPK cascade
7. Phosphorylation of nuclear proteins, transcription of glucokinase
43
RAS independent insulin signaling
1. Insulin binds to RTK
2. Autophosphorylation of receptor tyrosines
3. P-tyrosines recognized and bound by IRS1
4. IRS1 gets phosphorylated on its tyrosine residues by insulin receptor
5. P-IRS1 recruits P13-kinase
6. PI3-K phosphorlyates phosphoinositides to make PIP3
7. PIP3 acts as second messenger to recruit PKB to membrane and phosphorylate it to make it active
8. Active PKB (AKT) phosphorylates intracellular proteins
44
Glycogen synthesis promoted by _______
Activated glycogen synthase
45
RAS and Cancer
1. Mutated RAS, GEF and GAP implicated in human cancer
2. Mutations decrease intrinsic GTPase activity of RAS = locked in active state
3. Neurofibromatosis (nerve tissue tumor) caused by inactivating mutation in NF-1 gene that codes for GAP and RAS in nerves, uncontrollable nerve tissue growth.
46
Recognition Domains
1. Adaptor proteins (GRB2, IRS1) have SH2 domains or PTB domains that can recognize and bind to phosphorylated tyrosine residues on the receptor.
47
Small G-proteins
1. 150+ members of RAS family of G-proteins play role in transduction of signals from membrane receptors to effector proteins
2. Monomeric with 1 pp chain
3. Control cell proliferation, vesicular trafficking, survival, apoptosis, cell shape, polarity, membrane transport, secretion
4. RAS, RAB, RHO, ARF, RAN
48
Insulin Resistance
1. Loss of insulin stimulation of glucose uptake by GLUT4 in adipose and skeletal muscle
2. Reduced activation of PKB by insulin in obese people
3. Tyrosine phosphorylation of IRS1/2 is necessary to recruit PI3 kinase
4. Serine/threonine inactivates IRS and degrades
5. Serine/threonine phosphorylation of IRS1/2 stimulated by cytokines, FAs, and hyperinsulinemia
49
Signal transduction
Cascade of events that requires signals, receptors and effectors
50
Fast/Slow responses of cell signaling
Fast: Change in activity or function of ENZYMES or proteins in the cell, metabolic changes, fight/flight
Slow: Change in amounts of proteins by change in expression of genes
51
Effects of defective cell signaling
1. Leptin gene knockout mice
2. Cancer
3. ENDLESS POSSIBILITIES
52
What is cell signaling?
Getting messages from the outside to the inside of the cell.
53
2 types of signal responses
Fast (proteins, enzymes)
| Slow (gene expression)
54
3 main components of cell signaling
Signals, receptors, effectors
55
2 types of signal receptors
1. Intracellular receptors
| 2. Cell surface receptors
56
Hydrophobic vs. Hydrophilic Receptors
1. Hydrophobic molecules diffuse through membrane and bind to intracellular receptors.
2. Hydrophilic molecules can't diffuse and bind to cell-surface receptors (extracellular)
57
Example hydrophobic ligands and signals
Cortisol, estradiol, testosterone, thyroxine, vitamin D3, retinoic acid
58
Intracellular receptors are inactive by being bound to proteins -->
Ligands go to binding site, making conformational change in the receptor and allowing it to translocate to the nucleus.
59
3 main types of cell signaling receptors in PM
1. Ion channel coupled receptors (ligand gated)
2. GPCR
3. Enzyme coupled receptors (RTK)
60
How many subunits to a G-protein?
Alpha, beta, gamma
Alpha associates with effector enzyme
Beta/gamma release to allow alpha to perform, are docking proteins
Alpha subunit itself is not an enzyme
61
Do G-proteins have intrinsic catalytic activity?
No. G-proteins act on enzymes which perform the catalytic activity.
62
GEF vs GAP
GEF: GDP --> GTP (not phosphorylation)
GAP: GTP --> GDP, (accelerates intrinsic GTPase activity)
63
Adenylyl Cyclase
Effector molecule of GPCR (Gs), catalyzes formation of cAMP --> PKA
64
cAMP
1. Not recognized by kinases
2. Activates cAMP dependent PKA (tetramer 2/2)
3. Bind 2 cAMP molecules to regulator subunits and release active C subunits
4. Active PKA can phosphorylate other proteins
65
Signaling Amplification in cAMP Pathway
1. ONE activated receptor protein can activate MANY adenylyl cyclases through G-protein (Gs)
2. cAMP activates PKA --> enzymes
3. Amplification at each step of secondary messenger
66
Cholera Epidemic
1. Modifies G-protein by keeping Ga in GTP active form indefinitely (prevents hydrolyzation of GTP)
2. Leads to 100 fold increase in cAMP
3. PKA phosphorylates CFTR Cl- channel
4. Secretion of water
67
Desensitization of Signal
1. Turning off the signal
2. Decrease hormone levels
3. Remove signaling molecule (remove ligand)
4. Receptor sequestration by endosomes
5. Receptor destruction by endosomes + lysosomes (proteases)
68
Phosphodiesterases will remove cAMP
Idea is to remove the signaling molecule
69
G-protein receptor kinases (GRK) (GPCR-K)
1. GRK phosphorylates the receptor
2. Protein named ARRESTIN binds to protein
3. Ga can't interact, GDP can't convert to GTP
70
Gi/Go alpha G-proteins
1. Inhibit adenylyl cyclase
| 2. No cAMP production, no PKA activation
71
Gq alpha G-proteins
1. Activates phospholipase C (PLC) instead of adenylyl cyclase (AC)
72
Phospholipase C activation (PLC)
1. PLC cleaves PIP2
2. PIP2 --> IP3 and DAG (2nd messengers)
3. IP3 --> triggers Ca2+ release from endoplasmic reticulum
4. DAG activates PKC (major regulatory unit)
73
Protein Kinase C (PKC)
1. DAG induces conformational change in PKC and activates it
| 2. PKC phosphorylates membrane/cytoplasmic substrates.
74
Enzyme-coupled receptors (3)
1. Tyrosine Kinase receptors (RTK)
2. JAK-STAT receptors
3. Serine-threonine kinase receptors
All create docking sites for other proteins.
75
Tyrosine Kinase Receptors (RTK)
1. Single pass transmembrane domain
2. Enzymatic domain is on cytoplasmic tail
3. Induces dimerization of two receptor monomers
4. Autophosphorylation occurs
76
RTK Characteristics
1. RTK used to respond to growth factors
2. Growth factors are proteins released to promote growth of other cells
Growth factors are found in multiple cell types, not limited to where name states.
77
Growth factor = RTK, no GPCR relation
Growth factor = anything--GF
78
RTK Receptor Information
1. Activated receptor binds to proteins with SH2 domains
2. SH2 domain = Src homology
3. Src = first oncogene discovered
4. SH2 protein in mammals is Grb2 (adaptor protein)
79
RTK Receptor Mechanism
RTK --> SH2 (GRB2) --> SH3 (GRB2) --> SOS (GEF) --> RAS (ATP Bound) --> RAF
80
RAS is the most common oncogene
25% of cancers are RAS mutations
81
RAF mechanism
1. RAF/RAS complex initiates MAP kinase pathway
2. MAP Kinase-Kinase-Kinase reduces to MAP Kinase (ERK)
3. ERK regulates protein activity and changes in gene expression
4. Phosphorylation propagates the signal downstream
82
Insulin signaling
1. RAS independent (PI3K) and RAS dependent (GRB2)
2. RAS independent is fast, RAS dependent is slow
3. Receptor binds to IRS-1 intermediate --> GRB2 for slow pathway, PI3K for fast pathway
83
RTK effective pathway
RTK leads to gene transcription through MAP kinase pathway
84
Proto-oncogenes
Proto-oncogenes mutate into oncogenes and cause cancer.
85
JAK-STAT Receptors
1. More direct route for impacting gene transcription
2. Receptors bind cytokines, dimerize and bind JAKs
3. JAKs cross phosphorylate each other and receptor
4. Receptor binds and phosphorylates STATs
5. STATs dissociate from receptor, dimerize and translocate to nucleus
86
Serine-threonine receptors & Smad
1. More direct route
2. Activated receptor (dimer) phosphorylates R-Smad
3. R-Smad complexes with Co-Smad and migrates to nucleus
4. Smads can control cell proliferation AND differentiation
87
Src vs. RAS
1. Src was the first oncogene to be discovered
| 2. RAS mutations are found in 25% of cancers
